NEW YORK, NY – Two of the developers of Pfizer-BioNTech’s COVID-19 vaccine are now claiming that messenger RNA (mRNA) cancer vaccines are currently in the works, and should be hitting the market prior to 2030.
BioNTech co-founders professor Ozlem Tureci and her husband Ugur Sahin – who collaborated with Pfizer to create their company’s COVID jab – stated in an interview with the BBC that a “cure for cancer” could be a reality in the near future.
“We feel that a cure for cancer or to changing cancer patients’ lives is in our grasp,” Tureci said. “What we have developed over decades for cancer vaccine development has been the tailwind for developing the COVID-19 vaccine, and now the COVID-19 vaccine and our experience in developing it gives back to our cancer work. mRNA acts as a blueprint and allows you to tell the body to produce the drug or the vaccine.”
Tureci noted that the cancer vaccine should be released, “before 2030.” However, the husband and wife duo did not provide any additional details about the upcoming inoculation or their research into it.
The proclamation made by Tureci and Sahin comes on the heels of a recent announcement made by Moderna CEO Stephane Bancel – which has also produced a widely-used mRNA COVID vaccine – that his company is currently working with mRNA technology to create an injection that will be used to treat heart attack victims.
“We are now in a super exciting program where we inject mRNA in people’s hearts after a heart attack to grow back new blood vessels and re-vascularize the heart,” he said in an interview.
However, there are some critics that question the safety of mRNA-based technology, with Florida Surgeon General Joseph A. Ladapo recently releasing updated guidance regarding COVID-19 vaccines, recommending against their use in males aged 18-39 due to what he said is an increased risk of potentially fatal cardiac events.
or a specific category with our 
Comments are closed.